Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

This study has been terminated.

(Primary sponsor withdrew funding as of 12/2010 secondary to poor enrollment. Only 15 out of 60 needed enrolled after 2 years.)

Sponsor:

Collaborators:

University of Chicago

University of Illinois

Ruth M. Rothstein CORE Center

Abbott

Gilead Sciences

Information provided by (Responsible Party):

Allan Tenorio, MD, Rush University Medical Center

ClinicalTrials.gov Identifier:

NCT00775606

First received: October 17, 2008

Last updated: January 16, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2011
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)